Norris Medicines Limited (BOM:524414)
India flag India · Delayed Price · Currency is INR
14.75
-0.75 (-4.84%)
At close: Apr 28, 2026

Norris Medicines Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Apr '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2020 - 2016
Market Capitalization
14516813610535065
Upgrade
Market Cap Growth
-3.78%23.38%30.14%-70.10%437.69%131.32%
Upgrade
Enterprise Value
359383351319550241
Upgrade
Last Close Price
14.5116.7813.6010.4534.956.50
Upgrade
PS Ratio
1.542.882.411.253.700.53
Upgrade
PB Ratio
-0.91-1.13-1.00-0.84-3.27-0.87
Upgrade
P/FCF Ratio
-34.1780.658.94-6.34
Upgrade
P/OCF Ratio
-32.9080.118.71-5.84
Upgrade
EV/Sales Ratio
3.806.596.233.825.831.96
Upgrade
EV/EBITDA Ratio
75.83--34.52--
Upgrade
EV/EBIT Ratio
---108.08--
Upgrade
EV/FCF Ratio
-78.09208.2427.30-23.46
Upgrade
Debt / Equity Ratio
-1.35-1.45-1.58-1.72-1.97-2.47
Upgrade
Debt / EBITDA Ratio
45.33--23.13--
Upgrade
Debt / FCF Ratio
-43.95127.6318.30-17.93
Upgrade
Net Debt / Equity Ratio
-1.35-1.45-1.58-1.72-1.97-2.47
Upgrade
Net Debt / EBITDA Ratio
45.19-97.40-120.4323.11-334.03-10.54
Upgrade
Net Debt / FCF Ratio
-43.87127.4118.28-19.7817.91
Upgrade
Asset Turnover
-0.420.400.600.560.61
Upgrade
Inventory Turnover
-0.830.721.251.481.91
Upgrade
Quick Ratio
-0.140.120.140.160.16
Upgrade
Current Ratio
-0.630.670.640.630.70
Upgrade
Return on Assets (ROA)
--3.38%-3.36%1.32%-2.65%-7.46%
Upgrade
Return on Invested Capital (ROIC)
-0.68%-10.44%-8.93%3.06%-6.76%-18.30%
Upgrade
Return on Capital Employed (ROCE)
--20.70%-15.10%4.90%-9.70%-29.80%
Upgrade
Earnings Yield
-3.86%-7.37%-8.72%-16.74%-9.34%-76.33%
Upgrade
FCF Yield
-2.93%1.24%11.19%-3.05%15.78%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.